Risks With Xeloda
Xeloda® (capecitabine) is a chemotherapy medication commonly used to treat breast cancer and colorectal cancer. Although generally well tolerated, it is not without risks. For example, in clinical studies, up to 80 percent of people taking the drug developed anemia and up to 60 percent developed redness and tenderness of the palms and soles (hand-and-foot syndrome).
Other Xeloda risks involve more serious problems, such as depression, liver problems, or allergic reactions. While these side effects don't occur frequently, they are potentially dangerous and should be reported to a healthcare provider right away.
To reduce your risk of problems during treatment, talk to your healthcare provider before chemotherapy begins. In particular, let him or her know about any other medical conditions you have and any other medications you are taking.
(Click Xeloda Side Effects and Xeloda Warnings and Precautions to learn more about the risks associated with this drug. These articles go into more detail about why the medication may not be suitable for all situations. More information is also given on how Xeloda performed in clinical trials.)